Healthcare stocks declined late Monday afternoon, with the NYSE Healthcare Index falling 1.4% and the State Street Health Care Select Sector SPDR ETF (XLV) dropping 1.1%.
The iShares Biotechnology ETF (IBB) shed 1.4%.
In corporate news, Cardiff Oncology (CRDF) shares tumbled 22% after HC Wainwright downgraded the stock to neutral from buy, and TD Cowen downgraded the stock to hold from buy.